- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biomarkers in T cell therapy clinical trials ; volume:9 ; number:1 ; day:19 ; month:8 ; year:2011 ; pages:1-9 ; date:12.2011
Journal of translational medicine ; 9, Heft 1 (19.8.2011), 1-9, 12.2011
- Creator
-
Kalos, Michael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-138
- URN
-
urn:nbn:de:1111-2016041437452
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kalos, Michael
- SpringerLink (Online service)
Other Objects (12)
Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials
Using biomarkers prospectively in adaptive clinical trials
Strategies for cancer clinical trials with multiple biomarkers
Strategies for cancer clinical trials with multiple biomarkers
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Trends in clinical trials for articular cartilage repair by cell therapy
The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
Clinical trials for stem cell therapies
Identifying and Managing Sources of Variability in Cell Therapy Manufacturing and Clinical Trials
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age
Mapping the cell therapy landscape: insights into clinical trials and regulatory advances in China
Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials
Using biomarkers prospectively in adaptive clinical trials
Strategies for cancer clinical trials with multiple biomarkers
Strategies for cancer clinical trials with multiple biomarkers
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Trends in clinical trials for articular cartilage repair by cell therapy
The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
Clinical trials for stem cell therapies
Identifying and Managing Sources of Variability in Cell Therapy Manufacturing and Clinical Trials
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age
Mapping the cell therapy landscape: insights into clinical trials and regulatory advances in China
Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials
Using biomarkers prospectively in adaptive clinical trials
Strategies for cancer clinical trials with multiple biomarkers
Strategies for cancer clinical trials with multiple biomarkers
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Trends in clinical trials for articular cartilage repair by cell therapy
The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
Clinical trials for stem cell therapies
Identifying and Managing Sources of Variability in Cell Therapy Manufacturing and Clinical Trials
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age